Cell Culture Incubator Market Projected to Reach USD 4,305.1 Million by 2033 at a 6.4% of CAGR

Posted on 2024-07-18 by Future Market Insights in Healthcare, Pharmaceuticals // 0 Comments

Cell Culture Incubator Market

The global market for cell culture incubators market is set for significant growth, with an anticipated valuation of USD 2,315.5 million in 2023 and a projected increase to USD 4,305.1 million by 2033. This growth reflects a robust compound annual growth rate (CAGR) of 6.4% during the forecast period from 2023 to 2033, driven by increasing applications in research, clinical laboratories, and biotechnology industries.

Cell culture incubators are specialized devices designed to maintain optimal conditions such as temperature, pH, oxygen regulation, humidity, and CO2 concentration for the growth of cultured cells and bacterial cultures. These incubators play a critical role in various applications, including cell cultivation, tissue culture, in vitro fertilization (IVF), and stem cell research.

As research institutions and biotechnology companies focus on developing novel therapies and vaccines, the need for advanced cell culture technologies continues to grow. Cell culture incubators play a pivotal role in maintaining optimal conditions for cell viability and reproducibility, enhancing research outcomes and accelerating drug discovery processes.

Get your PDF – Sample Report

Bacteria and cell cultures are kept growing inside a chamber at carefully regulated temperature, humidity, pH, and CO2 concentration by a device called a cell culture incubator. The demand for more vaccines based on cell culture and its subsequent approvals are fueling the market for cell culture incubators. The rising prevalence of chronic illnesses and the growing need for monoclonal antibodies are predicted to drive growth in the target market.

A specialized scientific tool for the meticulously regulated development and preservation of cells is a tissue culture incubator. To promote the ideal conditions for cell formation and proliferation, it offers stable settings with regulated temperature, humidity, and gas concentrations.

Market Competition:

The key players of this market include Thermo Fisher Scientific Inc, Memmert GmbH + Co.KG, Binder GmbH, Panasonic, BioIVT, Sheldon Manufacturing, Inc.

Thermo Fisher Scientific Inc. announced in June 2021 that the company’s Thermo Scientific Cytomat 24 automated incubators and storage systems are combined with the latest technology to aid increased throughput and sample protection. The new Cytomat 24 automated incubators and storage systems from Thermo Fisher Scientific, which will be available in May 2021, provide a large capacity, quick access, and a wide temperature range while minimizing contamination difficulties in high-throughput applications. The new instruments use temperature consistency and stability to assure reproducibility for cell culture applications, while also providing speedy delivery of microtiter plates via an enhanced plate shuttle system, according to a press release issued by Thermo Fisher on May 14, 2021. The system also incorporates an LED touch screen that is installed on the door for easy access and viewing.
BioIVT released its GMP Grade Human AB Serum tailored for gene therapy manufacturing in January 2022. BioIVT’s GMP-grade human AB serum is manufactured with the same optimized processes and improved regulatory control of source material collection, manufacturing, and processing as its research-use only material. However, it also includes extra viral tests and documentation for hepatitis A (plasma-derived only), hepatitis B core antibody, hepatitis E, and parvovirus B19 (plasma-derived only).

Customization Available – Here

Key Segments Profiled In The Cell Culture Incubator Industry Survey:

By Type:

Air-jacketed
Water-jacketed
Direct Heat

By Sensor Technology:

Infra-red
Thermal Conductivity

By Application:

For Pharmaceutical Applications
For Biomedical and Clinical Labs
For Government Research
For IVF Processes
For Other Applications

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

Explore In-Depth Market Insights – Purchase Now to Access

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Matched content

Editor’s pick